Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells

H. Y. Chang, T. C. Huang, N. N. Chen, H. C. Huang, H. F. Juan

研究成果: 雜誌貢獻文章同行評審

37 引文 斯高帕斯(Scopus)


F1Fo ATP synthase is present in all organisms and is predominantly located on the inner membrane of mitochondria in eukaryotic cells. The present study demonstrated that ATP synthase and electron transport chain complexes were ectopically expressed on the surface of breast cancer cells and could serve as a potent anticancer target. We investigated the anticancer effects of the ATP synthase inhibitor citreoviridin on breast cancer cells through proteomic approaches and revealed that differentially expressed proteins in cell cycle regulation and in the unfolded protein response were functionally enriched. We showed that citreoviridin triggered PERK-mediated eIF2α phosphorylation, which in turn attenuated general protein synthesis and led to cell cycle arrest in the G0/G1 phase. We further showed that the combination of citreoviridin and the 26S proteasome inhibitor bortezomib could improve the anticancer activity by enhancing ER stress, by ameliorating citreoviridin-caused cyclin D3 compensation, and by contributing to CDK1 deactivation and PCNA downregulation. More interestingly, the combined treatment triggered lethality through unusual non-apoptotic caspase- and autophagy-independent cell death with a cytoplasmic vacuolization phenotype. The results imply that by boosting ER stress, the combination of ATP synthase inhibitor citreoviridin and 26S proteasome inhibitor bortezomib could potentially be an effective therapeutic strategy against breast cancer.
期刊Cell Death and Disease
出版狀態已發佈 - 1月 1 2014

ASJC Scopus subject areas

  • 細胞生物學
  • 免疫學
  • 癌症研究
  • 細胞與分子神經科學


深入研究「Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells」主題。共同形成了獨特的指紋。